Article
Molecular genotyping in medullary thyroid cancer.
Current opinion in oncology - 1 Jan 2023
Newbold Kate
Abstract excerpt
PURPOSE OF REVIEW: There has been a significant advance in our understanding of the molecular biology of medullary thyroid cancer (MTC) alongside progress in the development of targeted therapies including multikinase and specific rearranged during transfection inhibitors. RECENT FINDINGS: This review will examine the latest data investigating the impact of the genomics of MTC on the prediction of the natural...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
